NDC 50090-7339-01 - Ezetimibe

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
50090-7339
Requested NDC
50090-7339-01
Package NDCs from labels
50090-7339-0, 50090-7339-1, 50090-7339-01
Manufacturer
A-S Medication Solutions
Effective date
2024-10-21
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Ezetimibe - A-S Medication SolutionsA-S Medication Solutions2024-10-21HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-7339-0Ezetimibe30 in 1 BOTTLETABLET301
50090-7339-1Ezetimibe90 in 1 BOTTLETABLET901

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-7339EZETIMIBE TABLET [A-S MEDICATION SOLUTIONS]1Current NDC, 2 package rows20241023_5877150f-2807-435e-8e5b-a07dc7dbfd27.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-7339-0EA - Each50090-73393c9f6bf5-fc01-48cd-956a-a64eb94afe2d12024-11-05
50090-7339-1EA - Each50090-73394a0bfdb3-7e11-4cdb-a8e8-25ae48534ed212024-11-05

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 7 of 7 · 121 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EzetimibeEZETIMIBEProficient Rx LP5cbd9bce-e02d-440f-95d5-4eb958d2f4f32019-10-01Warnings, Adverse reactionsExact identifier
rxcui: 349556
unii: EOR26LQQ24

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.